Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2024 Earnings Call Transcript March 10, 2025
Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.1.
Operator: Hello everyone and welcome to the Coherus Fourth Quarter Year Ending 2024 Financial Results Conference call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be...
